• Maze Therapeutics CSBO Atul Dandekar exercised options for 7,500 shares at USD 10.42 on July 29, 2026.
• He sold 7,500 shares the same day for weighted-average prices of USD 27.31 and USD 27.89.
• Beneficial ownership in common stock fell to 26,250 shares following the transactions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Maze Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0002050167-26-000019), on July 31, 2026, and is solely responsible for the information contained therein.